Advent Life Sciences Investor

Advent Life Sciences is one of Europe's leading venture teams investing in life sciences businesses. The team consists of 11 professionals with extensive scientific, medical and operational experience, and a long-standing track record of entrepreneurial and investment success across the UK, Europe and the US. The Firm invests in a range of sectors within life sciences, principally in new drug discovery, enabling technologies, and med tech. Realisations in the last three years include Algeta, Avila, CN Creative, EUSA, Micromet. Current investments include Acutus, Biocartis, Cellnovo, f2G, NeRRe.
Technology: N/A
Industry: Longevity
Headquarters: London, England, United Kingdom
Founded Date: 2010
Employees Number: 11-50
Funding Status: N/A
Investor Type: Venture Capital
Investment Stage: N/A
Number Of Exits: 10

Visit Website
contact@adventLS.com
Register and Claim Ownership